臨床試験イメージングの世界市場予測2021：CT、MRI、PET、超音波、心エコー検査、X線検査...市場調査レポートについてご紹介

1 Introduction (Page No. – 14)
1.1 Objectives of The Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in The Study
1.4 Currency
1.5 Limitation
1.6 Stakeholders

2 Research Methodology (Page No. – 17)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Rank Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Key Industry Insights
2.3.4 Assumptions for The Study

3 Executive Summary (Page No. – 24)

4 Premium Insights (Page No. – 27)
4.1 Clinical Trial Imaging: Market Overview
4.2 Clinical Trial Imaging Market, By Product & Service, 2016
4.3 Clinical Trial Imaging Market Size, By Modality, 2016 vs 2021
4.4 Clinical Trial Imaging Market Size, By End User, 2016 vs 2021
4.5 Geographic Snapshot of The Clinical Trial Imaging Market
4.6 Life Cycle Analysis, By Region

5 Market Overview (Page No. – 32)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increase in R&D Spending
5.2.1.2 Growth in The Pharmaceutical and Biotechnology Industries
5.2.1.3 Increasing Number of Cros
5.2.2 Restraints
5.2.2.1 High Implementation Cost of Imaging Systems
5.2.3 Opportunities
5.2.3.1 Emerging Economies
5.2.3.2 Development of Innovative Imaging Modalities, Contrast Agents, Molecular Probes, and Radiopharmaceuticals
5.2.4 Challenges
5.2.4.1 High Cost of Clinical Trials
5.2.4.2 High Cost of Pet
5.3 Recent Market Trends
5.3.1 Rising Demand for Multimodality Imaging Technology in Clinical Trials
5.4 Regulatory Scenario
5.5 Clinical Trials: Global Scenario

6 Clinical Trial Imaging Market, By Product and Service (Page No. – 39)
6.1 Introduction
6.2 Services
6.2.1 Operational Imaging Services
6.2.2 Read Analysis Services
6.2.3 System and Technical Support Services
6.2.4 Trial Design Consulting Services
6.3 Software

7 Clinical Trial Imaging Market, By Modality (Page No. – 48)
7.1 Introduction
7.2 Computed Tomography
7.3 Magnetic Resonance Imaging
7.4 Ultrasound
7.5 Positron Emission Tomography
7.6 X-Ray
7.7 Echocardiography
7.8 Other Modalities

8 Clinical Trial Imaging Market, By End User (Page No. – 57)
8.1 Introduction
8.2 Pharmaceutical Companies
8.3 Biotechnology Companies
8.4 Medical Device Manufacturers
8.5 Contract Research Organizations
8.6 Academic and Government Research Institutes
8.7 Other End Users

9 Clinical Trial Imaging Market, By Region (Page No. – 68)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.4 Asia
9.5 Rest of The World (RoW)

10 Competitive Landscape (Page No. – 89)
10.1 Introduction
10.2 Strategic Overview
10.3 Competitive Situation and Trends
10.4 Leading Players in The Clinical Trial Imaging Market
10.4.1 Agreements, Collaborations, and Partnerships
10.4.2 Expansion
10.4.3 Acquisition
10.4.4 Product and Service Launches & Product Upgrades

11 Company Profiles (Page No. – 95)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Introduction
11.2 Bioclinica, Inc.
11.3 Parexel International Corporation
11.4 Icon PLC
11.5 Biomedical Systems Corporation
11.6 Biotelemetry, Inc.
11.7 Cardiovascular Imaging Technologies, LLC
11.8 Intrinsic Imaging LLC
11.9 Ixico PLC
11.10 Radiant Sage LLC
11.11 Worldcare Clinical, LLC
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 112)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.5 Introducing RT: Real-Time Market Intelligence
12.6 Available Customizations
12.7 Related Reports
12.8 Author Details